Sundial Growers Inc banner

Sundial Growers Inc
NASDAQ:SNDL

Watchlist Manager
Sundial Growers Inc Logo
Sundial Growers Inc
NASDAQ:SNDL
Watchlist
Price: 1.53 USD -7.83% Market Closed
Market Cap: $393.8m

P/OCF

7.9
Current
7%
Cheaper
vs 3-y average of 8.5

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
7.9
=
Market Cap
$352.9m
/
Operating Cash Flow
CA$70.9m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
7.9
=
Market Cap
$352.9m
/
Operating Cash Flow
CA$70.9m

Valuation Scenarios

Sundial Growers Inc is trading below its 3-year average

If P/OCF returns to its 3-Year Average (8.5), the stock would be worth $1.64 (7% upside from current price).

Statistics
Positive Scenarios
3/3
Maximum Downside
No Downside Scenarios
Maximum Upside
+39%
Average Upside
26%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 7.9 $1.53
0%
3-Year Average 8.5 $1.64
+7%
Industry Average 10.4 $2
+31%
Country Average 10.9 $2.12
+39%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
CA
Sundial Growers Inc
NASDAQ:SNDL
402.9m USD 7.9 -35.5
US
Eli Lilly and Co
NYSE:LLY
867B USD 51.6 42
US
Johnson & Johnson
NYSE:JNJ
555.4B USD 22.6 26.4
CH
Roche Holding AG
SIX:ROG
248.4B CHF 13.2 19.3
UK
AstraZeneca PLC
LSE:AZN
224.8B GBP 20.4 29.1
CH
Novartis AG
SIX:NOVN
221.8B CHF 14.6 20
US
Merck & Co Inc
NYSE:MRK
283.6B USD 17.2 15.5
IE
Endo International PLC
LSE:0Y5F
244.4B USD 907.7 -83.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 9.2 10.7
US
Pfizer Inc
NYSE:PFE
151.6B USD 13 19.5
US
Bristol-Myers Squibb Co
NYSE:BMY
118.8B USD 8.4 16.8
P/E Multiple
Earnings Growth PEG
CA
Sundial Growers Inc
NASDAQ:SNDL
Average P/E: 22.2
Negative Multiple: -35.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
42
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
26.4
8%
3.3
CH
Roche Holding AG
SIX:ROG
19.3
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
29.1
25%
1.2
CH
Novartis AG
SIX:NOVN
20
14%
1.4
US
Merck & Co Inc
NYSE:MRK
15.5
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.7
0%
N/A
US
Pfizer Inc
NYSE:PFE
19.5
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.8
16%
1.1

Market Distribution

In line with most companies in Canada
Percentile
34rd
Based on 1 917 companies
34rd percentile
7.9
Low
0.1 — 7.2
Typical Range
7.2 — 17
High
17 —
Distribution Statistics
Canada
Min 0.1
30th Percentile 7.2
Median 10.9
70th Percentile 17
Max 26 053.9

Sundial Growers Inc
Glance View

Market Cap
393.8m USD
Industry
Pharmaceuticals

Sundial Growers, Inc. is a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities. The company is headquartered in Calgary, Alberta and currently employs 394 full-time employees. The company went IPO on 2019-08-01. The Company’s segments include Cannabis Operations, Cannabis and Liquor Retail and Investment Operations. Its portfolio brands includes Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The firm operates the Spiritleaf retail banner. The firm also operates a private-sector retailers of alcohol in North America and Canada by number of stores, operating locations in Alberta and British Columbia. Its investment operations seek to arrange strategic capital through direct and indirect investments and partnerships throughout the global cannabis industry.

SNDL Intrinsic Value
1.23 USD
Overvaluation 20%
Intrinsic Value
Price $1.53
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett